We have searched articles published in various journals world wide on quality of life (Qol) after liver transplantation through internet; 38 articles were available through our searching process. After reviewing all papers we have found that there is no transplant specific assessment tool for measuring Qol after liver transplantation. General tools are used for assessment of Qol of these patients. Pretransplantation Qol are severely affected when compared to normal healthy volunteers. Hepatocellular carcinoma and cholestatic etiologies have higher Qol scores than those related to alcohol or viral hepatitis. Post-transplantation Qol scores are not affected by the etiology of the original liver cirrhosis, but transplant recipient scores continue to remain significant!)' . lower than those of healthy patient controls. The Qol scores improve during initial time after liver transplantation, but decreases in the long term. It may be due to decreases in the physical function and bodily pain domains as the patient's age increases, develops osteoporosis from long-term intake of steroids, and chronic rejection process. It is also addressed that Qol is not good in patients with Hepatitis C after liver transplantation. The development of a Qol assessment tool specific to transplantation could help to more accurately assess factors that alter post-transplantation Qol.
Introduction
It is essential to understand the quality of life (QoL) after surgery for any disease, particularly important in liver transplantation (LT) recipients because the magnitude of the program is huge. The surgery involves two lives in case of living donor related liver transplantation (LDLT}, one life and brain death related donor in case of deceased donor liver transplantation (DOLT}. A lot of investigations are needed for selecting the donor and also for checking the fitness of the recipient. The availability of suitable donor liver is also extremely less. The complexity of law for procurement of donor liver makes the liver transplantation program more difficult. A good infrastructure, huge skilled manpower, requirement of special instruments, and pre-, per-, postoperative medications makes the surgery more expensive for patients. Considering these facts it is important to know the QoL after liver transplantation. If the QoL is not favorable the existence of this program will be questionable; on the contrary if it is favorable the question of more expansion of the program will come ahead. There are numerous assessment tools for measuring QoL after LT published in various journals. Studies also published on the comparison result of QoL in cirrhotic patients before LT and QoL after LT using these measurement tools. Valid articles published on these issues are collected for discussing the pros and cons of quality of life after liver transplantation.
Qoltools
There are a number of tools used to measure QoL in transplant recipients 1 -3 
Pre-transplant Qol
Several studies assessed the QoL of cirrhotic patients and they found that it is clearly compromised in patients with cirrhosis when compared with the general population. In a study Saab et al. 6 found that ascites and/or encephalopathy ( component of Child-Turcotte-Pugh score) were significantly correlated with QoL score. These findings were confirmed by a study by Estraviz et al. 9 showing that Child-Turcotte-Pugh (CTP) classifications could be correlated with pretransplantation QoL scores. The study found that CTP class A patients had significantly higher overall QoL scores than CTP class C patients. Specifically, CTP class A patients had significantly higher scores in the SF-36 physical functioning, general health, vitality, and social functioninq domains as well as its mental summary component in comparison with CTP class C patients. In another study by Kanwal et al. 8 showed that QoL scores actually predicted mortality in patients with cirrhosis. All these studies support that the severity of liver disease correlate with QoL scores.
The etiology of liver disease also seems to affect pretransplantation QoL scores. Estraviz et al. 9 26 showed that alcohol-related and non-alcohol-related LT recipients appear to experience similar QoL scores, and they return to society to lead similarly active and productive lives for years after LT. In fact, studies show that HCV appears to be the only etiology of liver disease to negatively affect long-term QoL scores. 13, ,a.23
It is clear from above discussion that both mental and physical component of QoL decreases as the time passes after LT. The reason may be due to ageing process, development of osteoporosis, long-term use of immunosuppressive drugs, development of chronic cellular rejection, recurrent infection of transplanted liver by HCV infection and alcohol induced liver cirrhosis by resumption to alcohol consumption.
HCV induced liver disease and Qol after LT HCV is the most common indication for LT in the United
States and Europe. However, recurrent infection is universal, and recurrent disease can lead to graft failure in approximately 20% of transplant recipients within 5 years. Studies suggest that QoL scores experienced by LT recipients transplanted for HCV are lower than those of LT recipients transplanted for other indications such as HBV or alcoholic cirrhosis. 19 These findings suggest that diseases that recur appear to have a particularly pronounced effect on patient QoL scores post-LT. Indeed, multiple studies have shown that QoL scores for recipients transplanted for HCV are lower within the SF-36 QoL bodily pain and social function domains. In addition, both the physical and mental component SF-36 QoL scores are also low 16 , 22 -24 · 28 . However, studies designed to investigate this effect have shown that decreased QoL . scores do not correlate with the timing of any actual physical consequences of recurrent liver disease, the statistical occurrence of cirrhosis, or any medical complications of a patient's disease recurrence. Thus, what accounts for patients reporting lower generalized QoL scores? It appears that the impact of HCV recurrence on QoL as reported by post-LT patients is complicated by recipients' knowledge of their own viral status. For instance, a study conducted by Rodger et al. found that patients informed of HCV recurrence before taking QoL surveys scored lower than those with HCV recurrence who did not know their serostatus 29 , 30 . Patients assessed at both 6 and 12 months post-LT show that the psychological stress associated with disease recurrence is perceived as being more disabling and is a greater contributor to depression than any physical impairment secondary to disease sequelae 23 · 31 . In nontransplant patients, HCV recurrence is known to decrease QoL, usually because the antiviral therapy used to treat this recurrence is known to decrease QoL scores during treatment 29 , 32 , 33 . However, LT recipients transplanted for HCV report this decrease in QoL with the knowledge of HCV recurrence alone, without antiviral therapy or physical sequelae of recurrent disease.
Employment and Qol after LT
A surrogate marker of recipients' post-transplant functional status in society may be employability. Approximately 45% of LT recipients actually return to work after transplantation, and studies have demonstrated that better QoL is associated with posttransplantation employment 16 • 32 . In a study of over 300 LT recipients, Aberg et al. 34 showed that employed LT recipients experienced better QoL than unemployed recipients. The study found that patients transplanted for chronic liver diseases such as HBV or HCV returned to work in numbers similar to those of patients transplanted for acute liver failure and HCC 32 . Thus, the transplant indication does not appear to be a contributing factor to post-LT employment rates 32 . Likewise, the severity or duration of liver dysfunction prior to transplantation does not appear to correlate with employment rates after LT 32 , 35 . Alberg et al.'s study did find that patients transplanted at a younger age were more often able to return to work after LT 32 . It also showed that an earlier return to employment after LT was associated with higher QoL scores ( eg, patients who returned to work in 6 months had higher QoL scores than those who waited 1 to 2 years to return to work) 32 . Saab et al. 6 also studied employment and its effects on QoL after LT. The study found that employment rates after transplantation were higher in LT recipients who did not receive disability income coverage prior to transplantation, in patients who had health maintenance organization (HMO) or preferred provider organization (PPO) insurance, in patients who worked at least 20 to 40 hours per week prior to transplantation, and in patients who did not have diabetes. The study concluded that lower rates of post-LT employment were associated with lower QoL scores within the physical health domains, specifically the SF-36 QoL physical functioning and role physical domains 6 . Thus, both studies concluded that employment after LT is an indicator for higher QoL scores. In addition, lack of employment after LT appears to be more greatly influenced by prior socioeconomic factors rather than severity of pretransplantation or post-transplantation disease 6 , 32 , 35 Gender and Qol after LT Several studies have examined the effects of gender on post-LT QoL scores, and there appear to be conflicting data. A meta-analysis conducted by Bravata and Keeffe 36 concluded that there were no significant differences in QoL score reports on the basis of gender, but the study commented on the scarcity of reports in the literature on the topic. Moore et al. 37 concurred with Bravata et al.'s findings, but their study had an extremely small patient population, with only 10 LT candidates and 10 healthy controls. In contrast, Kober et al. 38 reported that men actually had lower QoL scores after LT than female recipients. The largest study to date, conducted by Cowling et al. 26 reported that female gender lowers QoL scores post-LT. The authors compared 88 male and 61 female LT recipients and showed that male recipients reported overall higher QoL scores than females 26 . When they controlled for disparities in education, they found that in the more highly educated population, males continued to have higher QoL scores than females. Among the less educated patients, there were no differences found between male and female QoL scores 26 . Thus, studies with larger patient populations that also match socioeconomic factors such as education, income levels, and marriage are needed before gender influences on QoL post-LT can definitively be determined. No studies have been explained why QoL after LT is better in male and educated peoples than female and non educated or less educated peoples. More studies may be required on this issue for getting the appropriate answer.
Limitations
There are several limitations for interpreting QoL data. First of all, data are based on patient self-reporting. Secondly, many studies are performed in the outpatient settings. Thus, patients who are lost from transplant program, or died or too ill to be seen as outpatients may not be captured in many quality of life data. This inherently excludes patients in poor condition at the time of assessment as well as those who have died. The third limitation to interpret QoL is the timing of assessment because the QoL assessment started after discharge from the hospital in follow up visit. The recipient, who had complications after LT, had physical, mental, social and financial sufferings. These are not reflected in those studies. The fourth limitation is that there is no transplantspecific QoL instrument routinely used. Most studies used SF-36 or disease-specific instruments that are related to one particular disease (eg, the CLDQ for recurrent hepatitis C). Finally economic and education status are not routinely assessed in many QoL instruments. Both economic status and level of education affect not only a patient's medical decision making but also a patient's perception of quality of life.
Conclusion
On the basis of above discussion we can conclude that pretransplantation QoL scores are affected by the etiology of liver cirrhosis, with hepatocellular and cholestatic etiologies having higher QoL scores than those related to alcohol or viral hepatitis. Posttransplantation QoL scores are not affected by the etiology of the original liver cirrhosis, but transplant recipient scores continue to remain significantly lower than those of healthy patient controls. During the first 6 months after liver transplantation, the majority of physical and mental components of QoL scores improve, but these increases are not sustained in the long term. At 1 year after liver transplantation, emotional and mental QoL scores begin to decrease. During postoperative years 1 to 5, episodes of acute cellular rejection and patient age over 60 years decrease physical function and overall QoL scores. Beyond 5 years after orthotopic liver transplantation, age over 60, osteoporosis, and episodes of chronic rejection decrease health-related quality of life scores through decreases in the physical function and bodily pain domains. Hepatitis C as an indication for liver transplantation is an independent factor in decreasing post-transplantation QoL scores. Further studies are necessary that include a complete evaluation of the effects of gender, socioeconomic status, education, and ethnicity in order to better understanding of the factors influencing post-liver transplantation QoL scores. The development of a QoL assessment tool specific to transplantation could help us to more accurately assess factors (such as immunosuppression) that alter post-transplantation Qol.
